T6266

PP2 (AG 1879,AGL 1879) is a effective inhibitor of Lck/Fyn (IC50:4/5 nM) , ~100-fold less potent to EGFR, inactive for ZAP-70, PKA and JAK2.

MLN3126 is an orally active, potent CCR9 antagonist. MLN3126 inhibits CCL25-induced calcium mobilization and chemotaxis in mouse primary thymocytes with an IC50 value of 6.3 nM for calcium influx inhibition.

Risperidone hydrochloride (R 64 766 hydrochloride) is a 5-HT2 receptor blocker, P-glycoprotein inhibitor, and dopamine D2 receptor antagonist, with activity on 5-HT2A (Ki: 4.8 nM) and dopamine D2 (Ki: 5.9 nM) receptors.

Tioclomarol is a coumarin anticoagulant and a vitamin K antagonist.

Glucosylceramide synthase-IN-2 (compound T-690) is a potent, blood-brain barrier-permeable, orally active inhibitor of glucosylceramide synthase (GCS), with IC50 values of 15 nM for human GCS and 190 nM for mouse GCS. It exhibits non-competitive inhibition of C8 ceramide and UDP glucose.

Antistaphylococcal agent 2 is an anti-staphylococcal therapeutic agent.

Carbonic anhydrase inhibitor 7 is a potent inhibitor of human carbonic anhydrase (hCA), acting on hCA IX (Ki: 6.5 nM), hCA II (Ki: 7.1 nM), hCA XII (Ki: 72.1 nM) and hCA I (Ki: 255.8 nM).

Anticancer agent 51 (compound 3d) is a potent anticancer compound (Ki: 731.62 nM) with activity against prostate cancer, indicating its potential for prostate cancer research.

CDK2-IN-12 (compound 10b) is a potent inhibitor of CDK2 (IC50: 11.6 μM) and exhibits inhibition of hCA subtypes I, II, IX, and XII with KI values of 3534, 638.4, 44.3, and 48.8 nM, respectively. Additionally, CDK2-IN-12 shows anti-cancer effects.

Tripelennamine citrate is an ethylenediamine derivative and is a potent histamine H1 receptor antagonist. tripelennamine citrate reduces histamine-induced allergic reactions in the body. tripelennamine citrate can be used to study rhinitis, conjunctivitis, allergic and anaphylactic reactions.